Losing and finding a way at C: new promise for pharmacologic ascorbate in cancer treatment.
Molecular and Clinical Nutrition Section, Digestive Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892-1372, USA. MarkL@mail.nih.gov
Mark
M
Levine
Michael Graham
MG
Espey
Qi
Q
Chen
D000818:Animals; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000494:pharmacology*; D001205:Ascorbic Acid / Q000031:analogs & derivatives / Q000494:pharmacology*; D016923:Cell Death / Q000187:drug effects; D048708:Cell Growth Processes / Q000187:drug effects / Q000235:genetics; D002986:Clinical Trials as Topic; D004357:Drug Synergism; D006801:Humans; D051379:Mice; D018345:Mice, Knockout; D009369:Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000503:physiopathology; D018673:Nutrition Policy; D029363:Organic Anion Transporters, Sodium-Dependent / Q000235:genetics; D060347:Sodium-Coupled Vitamin C Transporters; D027981:Symporters / Q000235:genetics
D029363:Organic Anion Transporters, Sodium-Dependent; D060347:Sodium-Coupled Vitamin C Transporters; D027981:Symporters; D001205:Ascorbic Acid